Andrew Martin

Active 1956–2026

244
Papers
32,926
Citations
79
h-index
186
i10-index

Citations

Citations per year for Andrew Martin1962: 2 citations1963: 2 citations1964: 3 citations1965: 1 citations1966: 4 citations1968: 3 citations1970: 2 citations1971: 3 citations1973: 1 citations1974: 1 citations1975: 1 citations1976: 4 citations1977: 1 citations1978: 1 citations1979: 1 citations1980: 5 citations1981: 3 citations1982: 1 citations1983: 3 citations1984: 3 citations1985: 1 citations1986: 1 citations1987: 1 citations1990: 6 citations1991: 8 citations1992: 7 citations1993: 16 citations1994: 21 citations1995: 19 citations1996: 19 citations1997: 24 citations1998: 22 citations1999: 23 citations2000: 44 citations2001: 48 citations2002: 44 citations2003: 66 citations2004: 68 citations2005: 86 citations2006: 136 citations2007: 147 citations2008: 143 citations2009: 168 citations2010: 169 citations2011: 206 citations2012: 203 citations2013: 202 citations2014: 210 citations2015: 192 citations2016: 170 citations2017: 203 citations2018: 212 citations2019: 547 citations2020: 696 citations2021: 834 citations2022: 679 citations2023: 630 citations2024: 996 citations2025: 531 citations2026: 29 citations1967: no citations, so this year is not shown1969: no citations, so this year is not shown1972: no citations, so this year is not shown1988–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,807 citing papers, 22% of this breakdownUnited Kingdom: 1,085 citing papers, 8.5% of this breakdownGermany: 861 citing papers, 6.7% of this breakdownChina: 856 citing papers, 6.7% of this breakdownAustralia: 596 citing papers, 4.7% of this breakdownCanada: 518 citing papers, 4.1% of this breakdownFrance: 479 citing papers, 3.8% of this breakdownItaly: 463 citing papers, 3.6% of this breakdownNetherlands: 321 citing papers, 2.5% of this breakdownJapan: 318 citing papers, 2.5% of this breakdownIndia: 297 citing papers, 2.3% of this breakdownSpain: 282 citing papers, 2.2% of this breakdown
0%22%Other 30.4%

Fields

  • Medicine39.2%
  • Biochemistry, Genetics and Molecular Biology13%
  • Computer Science8.6%
  • Engineering7.5%
  • Materials Science5.3%
  • Neuroscience5%
  • Other21.4%

Topics

  • Prostate Cancer Treatment and Research4.3%
  • Radiopharmaceutical Chemistry and Applications2.6%
  • Prostate Cancer Diagnosis and Treatment2.3%
  • Advanced Cellulose Research Studies1.9%
  • Biofuel production and bioconversion1.7%
  • Sepsis Diagnosis and Treatment1.4%
  • Other85.8%

Coauthors

All papers

Open in search
  1. [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Martin, Ian D. Davis, Arun Azad, Wei Chua, Ian D. Davis, Nattakorn Dhiantravan, Louise Emmett, Kate Ford, Michael S. Hofman, Roslyn J. Francis, Craig Gedye, Jeffrey C. Goh, Alex Guminski, Edward Hsiao, Amir Iravani, Anthony M. Joshua, Ian Kirkwood, Ailsa Langford, Nicola Jane Lawrence, Sze-Ting Lee, Peter Lin, Andrew Martin, William M. McDonald, Margaret McJannett, Siobhan Ng, David A. Pattison, Shakher Ramdave, Nisha Rana, Andrew Redfern, Natalie Rutherford, Shahneen Sandhu, Andrew M. Scott, Martin R. Stockler, Shalini Subramaniam, Thean Hsiang Tan, John Violet, Andrew Weickhardt, Scott Williams, Sonia Yip, Alison Y. Zhang - The Lancet 2021 cited by 1,082

  2. Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Zielinski, Christopher J. Sweeney - New England Journal of Medicine 2019 cited by 1,593

  3. An Empirical Method for Estimating the Degree of Crystallinity of Native Cellulose Using the X-Ray Diffractometer

    Authors: , , , - Textile Research Journal 1959 cited by 8,472

  4. PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey C. Goh, Alex Guminski, Anis Hamid, Mohammad B. Haskali, Rodney J. Hicks, Edward Hsiao, Amir Iravani, Anthony M. Joshua, Ian Kirkwood, Grace Kong, Edmond M. Kwan, Ailsa Langford, Nicola Jane Lawrence, Sze-Ting Lee, Jeremy Lewin, Peter Lin, Andrew Martin, William M. McDonald, Margaret McJannett, Kate Moodie, Declan G. Murphy, Siobhan Ng, David A. Pattison, Izabella Pokorski, Shakher Ramdave, Aravind S. Ravi Kumar, Andrew Redfern, Natalie Rutherford, Javad Saghebi, Shahneen Sandhu, Andrew M. Scott, Lavinia Spain, Martin R. Stockler, Shalini Subramaniam, Thean Hsiang Tan, Sue Ping Thang, Ben Tran, Roslyn E. Wallace, Andrew Weickhardt, Scott Williams, Sonia Yip, Alison Y. Zhang, Sonia Yip, Alison Y. Zhang - The Lancet Oncology 2022 cited by 266

  5. Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian D. Davis, Tim Akhurst, Ramin Alipour, Dale L. Bailey, Patricia Banks, Alexis Beaulieu, Louise Campbell, Megan Crumbaker, Nattakorn Dhiantravan, Anis Hamid, Mohammad B. Haskali, Terry Hung, Grace Kong, Nick Lawrence, Jeremy Lewin, Michael McCarthy, Kate Moodie, Declan G. Murphy, Andrew Nguyen, David Pook, Aravind Ravi Kumar, Paul Roach, Peter Roselt, Javad Saghebi, Geoffrey Schembri, Lavinia Spain, Shalini Subramaniam, Sue Ping Thang, Paul Thomas, Ben Tran, Roslyn E. Wallace, Sonia Yip - The Lancet Oncology 2023 cited by 199

  6. Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian D. Davis, Ehtesham Abdi, Suzanne Allan, Patricia Bastick, Stephen Begbie, Robert Blum, Karen Briscoe, Daniel Brungs, Sean Bydder, Bala Renuka Chittajallu, Michelle R. Cronk, Katharine Cuff, Ian D. Davis, Anthony Dowling, Mark Frydenberg, M. C. George, Lisa G. Horvath, Elizabeth Hovey, Anthony M. Joshua, Narayan Karanth, Ganessan Kichenadasse, Laurence E. Krieger, Gavin Marx, Maitham Mathlum, Louise Nott, Zulfiquer Otty, Francis Parnis, David Pook, Shahneen Sandhu, Sanjeev Sewak, Amanda Gwendolyn Stevanovic, Martin R. Stockler, Aneta Suder, Hsiang Tan, Javier Torres, Simon Troon, Craig Underhill, Andrew Weickhardt, Robert Zielinski, Tahir Abbas, Ghadeer Anan, Chris Booth, H. E. A. Campbell, Kim Chi, Joseph L. Chin, E. Chouinard, Bryan Donnelly, Darrel Drachenberg, Amir Faghih, Antonio Finelli, Sebastién J. Hotte, Krista Noonan, Scott North, Mohammad Rassouli, Neil Reaume, Ricardo Rendon, Fred Saad, Evgeny Sadikov, Éric Vigneault, Paweł Zalewski, John McCaffrey, Ray McDermott, Patrick G. Morris, Miriam O’Connor, Paul Donnellan, Dearbhaile M. O’Donnell, Dearbhaile O'Donnell, Peter C.C. Fong, Alvin Tan, Simon Chowdhury and 13 more - The Lancet Oncology 2023 cited by 188

  7. Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , - Nature Communications 2023 cited by 124

  8. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2015 cited by 628

  9. [177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Yan Zhang, Sonia Yip, Hayley Thomas, Ailsa Langford, Michael S. Hofman, Margaret McJannett, Andrew Martin, Martin R. Stockler, Ian D. Davis - The Lancet Oncology 2024 cited by 155

  10. Addition of a photocrosslinking amino acid to the genetic code of Escherichia coli

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2002 cited by 735

  11. Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Uwe Kordes, David E. Kram, Matija Snuderl, Leslie Bridges, Andrew Martin, Lawrence J. Doey, Safa Al‐Sarraj, Christopher Chandler, Bassel Zebian, Claire Cairns, Rachael Natrajan, Jessica K.R. Boult, Simon P. Robinson, Martin Sill, Ira J. Dunkel, Stephen W. Gilheeney, Marc K. Rosenblum, Debbie Hughes, Paula Proszek, Tobey J. MacDonald, Matthias Preusser, Christine Haberler, Irene Slavc, Roger J. Packer, Ho‐Keung Ng, Shani Caspi, Mara Popović, Barbara Faganel Kotnik, Matthew D. Wood, Lissa Baird, Monika A. Davare, David A. Solomon, Thale Kristin Olsen, Petter Brandal, Michael Farrell, Jane Cryan, Michael Capra, Michael Karremann, Jens Schittenhelm, Martin U. Schuhmann, Martin Ebinger, Winand N.M. Dinjens, Kornelius Kerl, Simone Hettmer, Torsten Pietsch, Felipe Andreiuolo, Pablo Hernáiz Driever, Andrey Korshunov, Lotte Hiddingh, Barbara C. Worst, Dominik Sturm, Marc Zuckermann, Olaf Witt, Tabitha Bloom, Clare Mitchell, Evelina Miele, Giovanna Stefania Colafati, Francesca Diomedi‐Camassei, Simon Bailey, Andrew S. Moore, Tim Hassall, Stephen P. Lowis, Maria Tsoli, Mark J. Cowley, David S. Ziegler, Matthias A. Karajannis, Kristian Aquilina, Darren Hargrave, Fernando Carceller, Lynley V. Marshall and 14 more - Cancer Discovery 2020 cited by 278

  12. Estimated Burden of Community-Onset Respiratory Syncytial Virus–Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014–15

    Authors: , , , , , , , , , , , , , , , , - Journal of the Pediatric Infectious Diseases Society 2019 cited by 128

  13. Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications

    Authors: , , , , , - Bioconjugate Chemistry 2019 cited by 228

  14. Evaluation of177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)

    Authors: , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2022 cited by 60

  15. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Harrison A. Edwards, Nicholas De Rosa, T. D. Stewart, Brent J. Doolan, Yonatan Kok, Kate Simpson, Zhi M. Low, Tom Kovitwanichkanont, Richard A. Scolyer, Haryana M. Dhillon, Janette L. Vardy, Steven J. Chadban, David G. Bowen, Andrew C. Chen, Diona L. Damian - New England Journal of Medicine 2023 cited by 99

  16. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - EP Europace 2018 cited by 392

  17. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003*

    Authors: , , , - Critical Care Medicine 2007 cited by 1,250

  18. TheraP: a randomized phase 2 trial of 177 Lu‐ PSMA ‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

    Authors: , , , , , , , , , , , , , - British Journal of Urology 2019 cited by 162

  19. A checklist for assessing the methodological quality of concurrent tES-fMRI studies (ContES checklist): a consensus study and statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Iman Ghodratitoostani, Gadi Gilam, Roland H. Grabner, Joel D. Greenspan, Georg Groen, Gesa Hartwigsen, Tobias U. Hauser, Christoph S. Herrmann, Chi‐Hung Juan, Bart Krekelberg, Stéphanie Lefebvre, Sook‐Lei Liew, Kristoffer H. Madsen, Rasoul Khayati, Nastaran Malmir, Paola Marangolo, Andrew Martin, Timothy J. Meeker, Hossein Mohaddes Ardabili, Marius Moisa, Davide Momi, Beni Mulyana, Alexander Opitz, Natasza Orlov, Patrick Ragert, Christian C. Ruff, Giulio Ruffini, Michaela Ruttorf, Arshiya Sangchooli, Klaus Schellhorn, Gottfried Schlaug, Bernhard Sehm, Ghazaleh Soleimani, Hosna Tavakoli, Benjamin Thompson, Dagmar Timmann, Aki Tsuchiyagaito, Ulrich Martin, Johannes Vosskuhl, Christiane Anne Weinrich, Mehran Zare-Bidoky, Xiaochu Zhang, Benedikt Zoefel, Michael A. Nitsche, Marom Bikson - Nature Protocols 2022 cited by 56

  20. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL

    Authors: , , , , , - Quality of Life Research 1999 cited by 671

  21. Efficient and Provably Secure Key Agreement for Modern Smart Metering Communications

    Authors: , , - Energies 2018 cited by 67

  22. Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Y. Zhang, Robert Zielinski, Christopher J. Sweeney, for the ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) - Journal of Clinical Oncology 2021 cited by 60

  23. 177Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I/II Trial

    Authors: , , , , , , , , , , , , , - Journal of Nuclear Medicine 2021 cited by 48

  24. Ontogeny of orientation flight in the honeybee revealed by harmonic radar

    Authors: , , , , , , , , , , - Nature 2000 cited by 332